Oruka Therapeutics, Inc. (ORKA) — SC 13D Filings
All SC 13D filings from Oruka Therapeutics, Inc.. Browse 2 Activist Stake Filing reports with AI-powered summaries and risk analysis.
SC 13D Filings (2)
-
Fairmount Funds Discloses Stake in Oruka Therapeutics
— Sep 6, 2024 Risk: medium
On September 6, 2024, Fairmount Funds Management LLC, along with its affiliates Fairmount Healthcare Co-Invest III L.P. and Fairmount Healthcare Fund II L.P., a -
Adage Capital Management Reports Stake in ARCA biopharma
— Apr 5, 2024 Risk: medium
Adage Capital Management, L.P. has filed a Schedule 13D on April 5, 2024, reporting beneficial ownership of ARCA biopharma, Inc. common stock. The filing indica
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX